N

NMS Group

91 employees

NMS Group is a provider of research and development services include oncology drug discovery, preclinical research, clinical development.

Basic info

Industry

research services

Sectors

Clinical development starting from First-Time-In-Man by Clioss
Discovery by Nerviano Medical Sciences
Turn-key oncological treatment from discovery to production
From formulation to production of the active principle by Nerpharma
Consumer Research
Preclinical research by Accelera

Date founded

2012

Funding rounds raised

Total raised

$221M

from 1 investors over 1 rounds

N

NMS Group raised $221M on January 21, 2022

Investors: PAG

FAQ